Tuesday 10:40 – 11:10 Silent Symposia Theatre
Optimisation vs early escalation in ulcerative colitis
In this interactive session, Dr Nick Kennedy and Dr Ben Disney will explore the optimisation of mesalazine treatment and the data surrounding early escalation of treatment in moderate ulcerative colitis patients. The session will include a collaborative panel & audience discussion. Tillotts products will be mentioned in this talk.
- Dr Nick Kennedy, Consultant Gastroenterologist, The Royal Devon and Exeter NHS Foundation Trust
- Dr Ben Disney, Consultant Gastroenterologist, University Hospital Coventry
For prescribing information and adverse event reporting information: https://www.tillotts.co.uk/octasa-pi-page/
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk. Adverse events should also be reported to Tillotts Pharma UK Ltd. Tel: 01522 813500.
PU-01180 | May 2023